anesthetic concerns for the patient with renal and …:在肾脏和患者的麻醉问题…

上传人:tia****nde 文档编号:69595889 上传时间:2019-01-14 格式:PPT 页数:43 大小:382.05KB
返回 下载 相关 举报
anesthetic concerns for the patient with renal and …:在肾脏和患者的麻醉问题…_第1页
第1页 / 共43页
anesthetic concerns for the patient with renal and …:在肾脏和患者的麻醉问题…_第2页
第2页 / 共43页
anesthetic concerns for the patient with renal and …:在肾脏和患者的麻醉问题…_第3页
第3页 / 共43页
anesthetic concerns for the patient with renal and …:在肾脏和患者的麻醉问题…_第4页
第4页 / 共43页
anesthetic concerns for the patient with renal and …:在肾脏和患者的麻醉问题…_第5页
第5页 / 共43页
点击查看更多>>
资源描述

《anesthetic concerns for the patient with renal and …:在肾脏和患者的麻醉问题…》由会员分享,可在线阅读,更多相关《anesthetic concerns for the patient with renal and …:在肾脏和患者的麻醉问题…(43页珍藏版)》请在金锄头文库上搜索。

1、Anesthetic Concerns for the Patient With Renal and Hepatic Disease,R4 ,Advanced renal or hepatic disease Systemic disease processes, affecting multiple organ systems. Fundamental defect in protein metabolism hyperammonemia or elevated BUN(markers for other circulating byproducts of protein metabolis

2、m). Defective ion transport across cell membranes, resulting in intracellular sodium and water accumulation. Imply abnormal handling of anesthetic drugs, multiorgan dysfunction, general debility, and specific problem associated with replacement therapy and transplantation. - A challenge to anesthegi

3、ologists.,Systemic Manifestations of Renal and Hepatic Disease,Chronic renal failure(1) Fluid and acid-base imbalance Dialysis : control metabolic acidosis, hyperkalemia, and CHF. In anuric patients, Only fluid loss is insensible(500ml/day) Excessive sodium intake - edema, hypertension. Excessive wa

4、ter intake - hyponatremia. In polyuric CRF, Urine output is normal, but concentrating ability is absent. Acute fluid loss - hypovolemia. A moderate anion gap acidosis Compensated by chronic respiratory alkalosis. Buffer base is depleted. Shock, diarrhea, or hypercatabolism(sepsis, trauma, steroid th

5、erapy). Profound metabolic acidosis.,Electrolyte imbalance Extracellular potassium Maintained in narrow range(3.5 to 5.0 mEq/l). Active intracellular transport by a sodium ATP pump at the cell membrane. Clinical and ECG manifestations of hyperkalemia(or hypokalemia) depend on potassium flux rather t

6、han the serum concentration. Catabolic stress, acidosis, potassium-sparing diuretics, erythrocyte transfusion Rapid, life-threatening hyperkalemia. Hypermagnesemia Muscle weakness, susceptibility to muscle relaxants. Hypomagnesemia Associated with hypokalemia, ventricular irritability.,Hyperphosphat

7、emia Increased bone deposition of calcium and hypocalcemia. Decreased renal synthesis of vitamin D. Hypocalcemia Secondary hyperparathyroidism and bone resorption. The syndrome of renal osteodystrophy. Treatment : vitamin D, calcium salts, phosphate binders(aluminium hydroxide), dietary phosphate re

8、striction. Hypophosphatemia( 2.5 mg/dl) Aggressive dialysis, aluminum hydroxide therapy, or TPN. The phosphate depletion syndrome Increased susceptibility to muscle relaxants, difficult ventilatory weaning, and CNS dysfunction.,Cardiovascular problems Systemic hypertension LVH(concentric or asymmetr

9、ic) Hyperlipidemia a high prevalence of accelerated atherosclerosis. Anemia and AV shunts hyperdynamic circulation with fixed low systemic vascular resistance. circulatory reserve is impaired. Myocardial ischemia, sepsis hypotension . Uremic pericarditis, hemorrhagic pericardial effusions.,Pulmonary

10、 problems Increased minute ventilation to compensate chronic metabolic acidosis. Hypoalbuminemia, decreased serum oncotic pressure, decreased muscle strength, immunosuppression. postoperative pulmonary edema, atelectasis, pneumonia. CAPD abdominal distension compromises ventilation and forced vital

11、capacity(FVC).,Impaired hematopoiesis Normochromic, normocytic anemia Hct. between 25 and 28%. Decreased erythrpoietin production by the kidney. Bone marrow depression(uremia, aluminum toxicity), decreased RBC survival, chronic blood loss from GI tract or laboratory studies. Uremic coagulopathy Abno

12、rmal platelet function(thrombocytopathy) occurs when BUN exceeds 60 to 80 mg/dl. Bleeding time prolonged( 15 minutes). Impaired platelet aggregation. d/t defective endothelial release of von Willebrand factor-factor VIII complex.,Impaired metabolic and immune function Hyperglycemia, hypertriglycerid

13、emia peripheral insulin resistance and decreased lipoprotein lipase activity in uremia. protein malnutrition(kwashiorkor, hypoalbuminemic malnutrition) dietary protein restriction, chronic albuminuria. Protein loss via CAPD(10 to 20 g/dl, 30 to 40 g/dl with peritonitis). Hypoalbuminemia, lowered col

14、loid oncotic pressure peripheral edema, pulmonary edema. Impaired leukocyte chemotaxis and immunoglobulin responses nosocomial or oppportunistic infection. Depleted lean body mass and catabolic effects of uremia. wound dehiscence, fistulas, bed sores.,Gastrointestinal dysfunction (Uremic enteropathy

15、) Anorexia, hiccups, nausea, vomiting. Autonomic neuropathy delays gastric emptying. Regurgitation and aspiration during anesthetic induction. Peptic ulcer up to 25% in CRF patients. Hepatitis B and C high incidence in patients on chronic hemodialysis. often anicteric or in a carrier state.,Neurolog

16、ic dysfunction Depend on the acuity of uremia. Personality changes, drowsiness, asterexis, myoclonus, seizures. Major surgery, gastrointestinal bleeding, infection precipitate acute encephalopathy. Lifetime hospital dependence passive-aggressive, depressed, manipulative, and churlish. Uremic distal sensorimotor neuropathy a marker for autonomic neuropathy. orthostatic hypotension, impaired circulatory response to anesthesia, delayed gastric emptying. silent myocardial ischemia(without a

展开阅读全文
相关资源
相关搜索

当前位置:首页 > 高等教育 > 大学课件

电脑版 |金锄头文库版权所有
经营许可证:蜀ICP备13022795号 | 川公网安备 51140202000112号